Valeant to cut Addyi, dermatology sales forces -memo

NEW YORK (Reuters) - Valeant Pharmaceuticals International Inc will cut its sales force for Addyi, a treatment aimed at female sexual dysfunction, as well as some employees who sell dermatology products, according to an internal memo seen by Reuters.

http://ift.tt/1V5mxcK

from Reuters: Health News
via animenewspro